MPLT

MapLight Therapeutics, Inc. MPLT

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-60.19M

Quarter to Jun 30

Free cash flow

$-44.89M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$940.98M total
Novo Holdings A/S
$132.13M0.0%
FCPM III SERVICES B.V.
$115.63M0.0%
T. Rowe Price Investment Management, Inc.
$99.70M-0.7%
GOLDMAN SACHS GROUP INC
$69.83M-2.3%
PRICE T ROWE ASSOCIATES INC /MD/
$51.00M+1162.5%
BlackRock, Inc.
$36.74M-23.5%
Nan Fung Group Holdings Ltd
$34.81M0.0%
5AM Venture Management, LLC
$34.05M0.0%
Sanofi
$32.69M0.0%
STATE STREET CORP
$30.54M+151.3%
FMR LLC
$29.52M+302.7%
VANGUARD CAPITAL MANAGEMENT LLC
$28.10M+8.9%
Blue Owl Capital Holdings LP
$26.16M-27.4%
Paradigm Biocapital Advisors LP
$24.58MNew
Pivotal bioVenture Partners Investment Advisor LLC
$21.91M0.0%
Velan Capital Investment Management LP
$17.67M0.0%
Siren, L.L.C.
$16.13M0.0%
Capital World Investors
$14.90MNew
GEODE CAPITAL MANAGEMENT, LLC
$14.41M-16.4%
BAKER BROS. ADVISORS LP
$13.07M0.0%
DAFNA Capital Management LLC
$6.13M0.0%
BNP Paribas Asset Management Holding S.A.
$6.12M-36.2%
Freestone Grove Partners LP
$6.05M-46.2%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$4.90M-15.1%
MILLENNIUM MANAGEMENT LLC
$4.62MNew
See all 106 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MPLT

Earnings Per Share

13fpro.ai/company/MPLT

Loading ratio trend…

MPLT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MapLight Therapeutics, Inc. (MPLT): stock profile, AI score and financials

MapLight Therapeutics, Inc. (MPLT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MPLT is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), MapLight Therapeutics, Inc. reports net income of $-60.2M, free cash flow of $-44.9M. Top institutional holders of MPLT by reported 13-F value include Novo A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, based on the most recent SEC filings. MPLT trades on the Nasdaq exchange and files with the SEC under CIK 1770069. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MPLT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MapLight Therapeutics, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1770069 →